Diabetes drug reduces OSA severity in adults with obesity, study shows

Diabetes drug reduces OSA severity in adults with obesity, study shows

Type 2 diabetes drug tirzepatide has been shown to be effective in treating moderate to severe sleep apnoea in a worldwide clinical trial.

US researchers showed that tirzepatide (Mounjaro) — a GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist (RA) — can…

[ad_2]

Source link

More From Author

Therapist Reveals Her 3 Biggest Pet Peeves About The Mental Health Space

Therapist Reveals Her 3 Biggest Pet Peeves About The Mental Health Space

The Prevalence and Associated Factors of Post-COVID-19 Fatigue: A Systematic Review and Meta-Analysis

The Prevalence and Associated Factors of Post-COVID-19 Fatigue: A Systematic Review and Meta-Analysis

Leave a Reply

Your email address will not be published. Required fields are marked *